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We were interested and encouraged to read the recent letter calling for international 
collaborations on the topic of cerebral microbleeds (CMBs) 
(http://www.thelancet.com/journals/laneur/article/PIIS1474-4422(16)30124-7/fulltext). Key 
questions remain about the clinical relevance of CMBs, particularly regarding their potential 
role as a marker of bleeding-prone arteriopathies and intracerebral haemorrhage risk in 
patients treated with antithrombotic agents following ischaemic stroke or TIA.1,2 We agree 
that single-centre studies are unlikely to fully answer all of the important scientific questions 
about CMBs; international collaboration is essential to increase the scale of data available, 
maximizing scientific and statistical power. Collaborative research networks relating to 
CMBs have developed over recent years.3 We wish to raise awareness of the recently 
established Microbleeds International Collaborative Network, which arose from two large 
multicentre inception cohort studies addressing the key question of whether CMBs are 
associated with increased bleeding risk on oral anticoagulants in patients following ischaemic 
stroke or TIA:  Clinical Relevance of Microbleeds in Stroke (CROMIS-
2;https://www.ucl.ac.uk/cromis-2, and https://clinicaltrials.gov/ct2/show/NCT02513316) and 
Intracerebral Hemorrhage Due to Oral Anticoagulants: Prediction of the Risk by Magnetic 
Resonance (HERO;  http://heropub.pic.es; https://clinicaltrials.gov/ct2/show/NCT02238470). 
Together, CROMIS-2 and HERO have successfully recruited over 2500 patients from over 
110 hospitals in the UK and Spain, and will report their first results in 2017. The teams 
leading these observational studies, together with investigators leading other relevant study 
groups and cohort studies worldwide, have established a Microbleeds International 
Collaborative Network. We aim to undertake high quality large-scale robust pooled analyses 
relating to CMBs that are free from biases, including selective inclusion and outcome 
reporting.  With these aims in mind, our first project is a systematic review and individual 
patient data meta-analysis of the clinical relevance of CMBs in patients with TIA and 
ischaemic stroke (the prospectively registered protocol is published at: 
http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42016036602). This 
project is conducted according to the PRISMA-IPD standards for reporting systematic 
reviews and individual patient data meta-analyses.  We held a successful investigator 
workshop at the European Stroke Organisation Conference in Barcelona, May 2016, with 
input from 16 groups from 14 countries worldwide, who worked to finalize the protocol and 
set timelines. Following this workshop, our team has access to data from over 10000 
individuals (Table); we warmly welcome other investigators to contribute to expanding this 
research effort.  
Important work is also needed to standardize acquisition sequences, lesion definition and 
measurement, and post-processing of neuroimaging markers of small vessel disease. 
Members of the Microbleeds International Collaborative Network thus work closely with 
large-scale international harmonization initiatives including STRIVE4 and COEN.5 
 
Large-scale collaborative systematic reviews and pooled analyses will provide the strongest 
evidence to incorporate CMB imaging into clinical practice, including precise estimates of 
the ischaemic stroke and intracerebral haemorrhage risks associated with antithrombotic 
(antiplatelet and anticoagulant) drug exposure in patients with CMBs. The Microbleeds 
International Collaborative Network endorses the need for global collaboration on CMBs and 
small vessel disease research more widely; full, open communication and collaboration are 
essential to avoid unplanned duplication of effort. We look forward to working with other 
researchers worldwide to tackle the many outstanding research questions relating to CMBs.  
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